Affyimmune Therapeutics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
22 Strathmore Rd, Natick, Massachusetts,...Phone Number
(617) 699-1965Website
www.affyimmune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Affyimmune Therapeutics
AffyImmune is a clinical stage biotechnology company focused on developing technologies that expand the utility and improve the safety and efficacy of cell-based immunotherapy for cancer. AffyImmune was founded in 2016 and based in Natick, Massachusetts.Explore more
Affyimmune Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Affyimmune Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Affyimmune Therapeutics had a recent Job posting/layoffs
Check out if Affyimmune Therapeutics is spiking on competitors!
Check if Affyimmune Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Affyimmune Therapeutics
Funding: Get notified immidiatlly once Affyimmune Therapeutics has new funding data
Earning: See what the market has to say on Affyimmune Therapeutics recently announced quarterly report
Affyimmune Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Affyimmune Therapeutics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Affyimmune Therapeutics
Compare insights from companies similar to Affyimmune Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Affyimmune Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Affyimmune Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Affyimmune Therapeutics.
Affyimmune Therapeutics financials insights
Gather financial insights about Affyimmune Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$30M
Affyimmune Therapeutics Tech Stack
A closer look at the technologies used by Affyimmune Therapeutics
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Open Position
Open Position
Affyimmune Therapeutics News & Media
AffyImmune Appoints Deyaa Adib, MD as Chief Medical Officer
NATICK, Mass., Nov. 25, 2024 /PRNewswire/ -- AffyImmune Therapeutics, a clinical-stage biotechnology company committed to developing its novel, first-in-class ICAM-1 targeting chimeric antigen receptor (CAR) T cell therapy for solid tumors, today announced the appointment of Deyaa Adib, M....AffyImmune Appoints Drs. Rick Rutter and Jorge Nieva to Board of Directors
NATICK, Mass.--(BUSINESS WIRE)-- #CART--AffyImmune Appoints Drs. Rick Rutter and Jorge Nieva to Board of DirectorsAffyImmune Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AIC100 in Recurrent Anaplastic Thyroid Cancer
NATICK, Mass.--(BUSINESS WIRE)-- #CART--AffyImmune Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AIC100 in Recurrent Anaplastic Thyroid CancerAffyImmune Appoints Dr. Daniel Janse as Chief Executive Officer
NATICK, Mass.--(BUSINESS WIRE)-- #CART--AffyImmune Appoints Dr. Daniel Janse as Chief Executive Officer
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Affyimmune Therapeutics
Sign Up For FreeTo access detailed company insights
AffyImmune is a clinical stage biotechnology company focused on developing technologies that expand the utility and improve the safety and efficacy of cell-based immunotherapy for cancer. AffyImmune was founded in 2016 and based in Natick, Massachusetts.... Read More
